(Q34127007)

English

Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

phosphorylation

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Christopher R Garrett

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Domenico Coppola

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Robert M Wenham

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Christopher L Cubitt

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Anthony M Neuger

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Timothy J Frost

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Richard M Lush

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Daniel M Sullivan

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jin Q Cheng

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Saïd M Sebti

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

20 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1381-1389

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

Exploiting the PI3K/AKT pathway for cancer drug discovery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

Cellular survival: a play in three Akts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4612514

5 July 2018

The synthesis of 6-amino-4-methyl-8-(β-D-ribofuranosyl) (4-H,8-H)pyrrolo-[4,3,2-de]pyrimido[4,5-c]pyridazine, a new tricyclic nucleoside

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

A Phase II Trial of Tricyclic Nucleoside Phosphate in Patients with Advanced Squamous Cell Carcinoma of the Cervix

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

Will kinase inhibitors have a dark side?

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

A rational approach to personalized anticancer therapy: chemoinformatic analysis reveals mechanistic gene-drug associations.

1 reference

https://api.crossref.org/works/10.1007%2FS10637-010-9479-2

21 January 2018

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/20644979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20644979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of tricyclic nucleoside phosphate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20644979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20644979

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-010-9479-2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34127007&oldid=2196283593"